Johannes Drach

12.2k total citations
177 papers, 7.4k citations indexed

About

Johannes Drach is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Johannes Drach has authored 177 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 99 papers in Hematology, 73 papers in Molecular Biology and 66 papers in Oncology. Recurrent topics in Johannes Drach's work include Multiple Myeloma Research and Treatments (81 papers), Lymphoma Diagnosis and Treatment (48 papers) and Chronic Lymphocytic Leukemia Research (29 papers). Johannes Drach is often cited by papers focused on Multiple Myeloma Research and Treatments (81 papers), Lymphoma Diagnosis and Treatment (48 papers) and Chronic Lymphocytic Leukemia Research (29 papers). Johannes Drach collaborates with scholars based in Austria, United States and Czechia. Johannes Drach's co-authors include H. Huber, H. Kaufmann, Niklas Zojer, Michael Andreeff, Christoph Zielinski, Markus Raderer, Doris Drach, Andreas Chott, Heinz Ludwig and Heinz Gisslinger and has published in prestigious journals such as New England Journal of Medicine, The Journal of Experimental Medicine and Journal of Clinical Oncology.

In The Last Decade

Johannes Drach

174 papers receiving 7.2k citations

Peers

Countries citing papers authored by Johannes Drach

Since Specialization

Citations

This map shows the geographic impact of Johannes Drach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johannes Drach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johannes Drach more than expected).

Fields of papers citing papers by Johannes Drach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johannes Drach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johannes Drach. The network helps show where Johannes Drach may publish in the future.

Co-authorship network of co-authors of Johannes Drach

This figure shows the co-authorship network connecting the top 25 collaborators of Johannes Drach. A scholar is included among the top collaborators of Johannes Drach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johannes Drach. Johannes Drach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell Lymphoma 2015 ·New England Journal of Medicine ·Tadeusz Robak, Huiqiang Huang, Jie Jin, Jun Zhu, Ting Liu, Olga Samoilova, Halyna Pylypenko, Gregor Verhoef, Noppadol Siritanaratkul, Evgenii A. Osmanov, Julia Alexeeva, Juliana Pereira, Johannes Drach, Jiří Mayer, Xiaonan Hong, Rumiko Okamoto, Lixia Pei, Brendan Rooney, Helgi van de Velde, Franco Cavalli	261
2	Screening for adenoviruses in haematological neoplasia: High prevalence in mantle cell lymphoma 2013 ·European Journal of Cancer ·Karin Kosulin, Margit Rauch, Peter F. Ambros, Ulrike Pötschger, Andreas Chott, Ulrich Jäger, Johannes Drach, Alexander Nader, Thomas Lion	6
3	Overexpression of G protein‐coupled receptor 5D in the bone marrow is associated with poor prognosis in patients with multiple myeloma 2012 ·European Journal of Clinical Investigation ·Johanna Atamaniuk, Andreas Gleiß, Edit Porpaczy, Birgit Kainz, Thomas W. Grunt, Markus Raderer, Bernadette Hilgarth, Johannes Drach, Heinz Ludwig, Heinz Gisslinger, Ulrich Jaeger, Alexander Gaiger	101
4	Genome-Wide Transcriptional Response to 5-Aza-2′-Deoxycytidine and Trichostatin A in Multiple Myeloma Cells 2008 ·Cancer Research ·Gerwin Heller, Wolfgang M. Schmidt, Barbara Ziegler, (unknown), Leonhard Müllauer, Martin Bilban, Christoph Zielinski, Johannes Drach, Sabine Zöchbauer‐Müller	132
5	Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myeloma 2008 ·Blood ·Heinz Ludwig, Roman Hájek, Elena Tóthová, Johannes Drach, Zdeněk Adam, Boris Labar, Miklós Egyed, Ivan Špıčka, Heinz Gisslinger, Richard Greil, Ingrid Kühn, Niklas Zojer, Axel Hinke	148
6	Chemotherapy with cyclophosphamide, doxorubicin, etoposide, vincristine and prednisone (CHOEP) is not effective in patients with enteropathy-type intestinal T-cell lymphoma 2004 ·Annals of Oncology ·Stefan Wöhrer, Andreas Chott, Johannes Drach, Andreas Püspök, Michael Hejna, M. Hoffmann, Markus Raderer	37
7	Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP) 2003 ·Annals of Oncology ·Stefan Wöhrer, Johannes Drach, Michael Hejna, Werner Scheithauer, Albert Dirisamer, Andreas Püspök, Andreas Chott, Markus Raderer	46
8	New developments and treatment in multiple myeloma: new insights on molecular biology 2002 ·Annals of Oncology ·Johannes Drach, H. Kaufmann	6
9	Lack of Evidence for Involvement of Fetal Microchimerism in Pathogenesis of Primary Biliary Cirrhosis 2002 ·Digestive Diseases and Sciences ·Maximilian Schöniger–Hekele, Christian Müller, Jutta Ackermann, Johannes Drach, Friedrich Wrba, Edward Penner, Péter Ferenci	17
10	Chromosomal aberrations are shared by malignant plasma cells and a small fraction of circulating CD19⁺ cells in patients with myeloma and monoclonal gammopathy of undetermined significance 2002 ·British Journal of Haematology ·Niklas Zojer, J. C. Schuster, (unknown), Jutta Ackermann, Kathrin Strasser, Wolfgang Hübl, Johannes Drach, Heinz Ludwig	21
11	Deletion of chromosome 13q14 detected by fluorescence in situ hybridization has prognostic impact on survival after high-dose therapy in patients with multiple myeloma 2001 ·Annals of Hematology ·Nina Worel, Hildegard Greinix, J Ackermann, H. Kaufmann, (unknown), (unknown), Heinz Gisslinger, Klaus Lechner, Peter Kalhs, Johannes Drach	23
12	Advances in the biology and therapeutic management of multiple myeloma 2001 ·Annals of Hematology ·H. Kaufmann, (unknown), J Ackermann, H Huber, Johannes Drach	13
13	Aneuploidy of chromosome 7 can be detected in invasive lung cancer and associated premalignant lesions of the lung by fluorescence in situ hybridisation 2000 ·Lung Cancer ·(unknown), Gerhard Dekan, Jutta Ackermann, Michael Fiegl, H. Kaufmann, Johannes Drach, H. Huber	28
14	Expression of the lung resistance protein predicts poor outcome in patients with multiple myeloma. 1999 ·PubMed ·Martin Filipits, Johannes Drach, Gudrun Pohl, J. C. Schuster, Thomas Stranzl, J Ackermann, Robert Königsberg, H. Kaufmann, (unknown), H. Huber, H. Ludwig, Robert Pirker	39
15	Trisomy 13 is Associated with Poor Prognosis in Idiopathic Myelofibrosis with Myeloid Metaplasia 1999 ·Leukemia & lymphoma ·Niklas Zojer, Johannes Meran, Michael Vesely, (unknown), Jutta Ackermann, (unknown), (unknown), R. Heinz, Johannes Drach, Heinz Ludwig	5
16	Deletions of the region 17p11-13 in advanced melanoma revealed by cytogenetic analysis and fluorescence in situ hybridization 1998 ·British Journal of Cancer ·(unknown), Hendrati Pirc‐Danoewinata, J Ackermann, Johannes Drach, (unknown), Burkhard Jansen, K. Wolff, Hubert Pehamberger, Christine Marosi	8
17	Expression of MDR1 by Normal Bone Marrow Cells and its Implication for Leukemic Hematopoiesis 1995 ·Leukemia & lymphoma ·Johannes Drach, Shourong Zhao, Doris Drach, Martin Körbling, Heike Engel, Michael Andreeff	18
18	Expression of multidrug resistance (mdr-1) and p53 genes in hematologic cell systems: Implications for biology and gene therapy 1993 ·Michael Andreeff, Saili Zhao, Doris Drach, S. Hegewisch-Becker, Jeremy Rees, (unknown), Elie G. Hanania, Martin Körbling, A. B. Deisseroth, Johannes Drach	4
19	Immunoglobulin Gene Rearrangement in Plasma Cell Dyscrasias: Detection of Small Clonal Cell Populations in Peripheral Blood and Bone Marrow 1993 ·Leukemia & lymphoma ·Falko Fend, Katharina Weyrer, Johannes Drach, (unknown), (unknown), Kurt Grünewald	12
20	Flow cytometric determination of atypical antigen expression in acute leukemia for the study of minimal residual disease 1992 ·Cytometry ·Johannes Drach, Doris Drach, H. Glassl, Claus Gattringer, H. Huber	61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact